스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - allium cepa ferm 34a (hab) tm, barium citricum d10 aquos. (hab 8b), cutis feti bovis gl d4 (hab 41b), hirudo medicinalis ex animale toto gl tm (hab 41c), mesenchym bovis gl d4 (hab 41b), polygonatum odoratum e radice rec. ferm 33 d d2 (hab 33d), rosmarini aetheroleum (rosmarinus officinalis l., aetheroleum), thuja occidentalis e summitatibus recens ferm 33e d6 (hab 33e), vespa crabro ex animale toto d3 (hab 41c), silicea colloidale (ex liquor natrii silicici et acidum citricum monohydricum) - gel - allium cepa ferm 34a (hab) tm 10 mg, barium citricum d10 aquos. (hab 8b) 10 mg, cutis feti bovis gl d4 (hab 41b) 10 mg, hirudo medicinalis ex animale toto gl tm (hab 41c) 10 mg, mesenchym bovis gl d4 (hab 41b) 10 mg, polygonatum odoratum e radice rec. ferm 33 d d2 (hab 33d) 10 mg, rosmarini aetheroleum (rosmarinus officinalis l., aetheroleum) 5 mg, thuja occidentalis e summitatibus recens ferm 33e d6 (hab 33e) 10 mg, vespa crabro ex animale toto d3 (hab 41c) 10 mg, aqua purificata, glycerolum, cyamopsidis seminis pulvis, natrii alginas, silicea colloidale (ex liquor natrii silicici et acidum citricum monohydricum) 10 mg, thymi aetheroleum, ad gelatum pro 1 g. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - médicaments anthroposophiques

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - prunus spinosa e floribus et summitatibus ferm cum ferro d6 (hab 37a) - solution injectable (s. c.) - zulassung gilt auch für alle höheren folgepotenzen: prunus spinosa e floribus et summitatibus ferm cum ferro d6 (hab 37a) 1000 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.48 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - médicaments anthroposophiques

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

wala schweiz ag - abies alba e summitatibus ferm 33d d2 (hab 33d), petasites hybridus e radice rec. ferm 33c d2 (hab 33c), plantago lanceolata e foliis ferm 34c d2 (hab 34c) - solution injectable (s. c.) - abies alba e summitatibus ferm 33d d2 (hab 33d) 100 mg, petasites hybridus e radice rec. ferm 33c d2 (hab 33c) 100 mg, plantago lanceolata e foliis ferm 34c d2 (hab 34c) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.51 mg. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - médicaments anthroposophiques

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

arko diffusion sa - hyperici summitatum cum floribus extractum ethanolicum siccum - gélules - hyperici summitatum cum floribus extractum ethanolicum siccum 185 mg corresp. hypericinum 0.55 mg, der: 4-7:1, excipiens pro capsula. - en cas de baisse d'humeur - phytotherapeutika

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

weleda ag - prunus spinosa - tropfen / spray - d2, b ab/ab d2, d ab/ab d4 - anthroposophisch

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

weleda ag - prunus spinosa - tropfen / spray - d2, b ab/ab d2, d ab/ab d4 - anthroposophisch

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

weleda ag - prunus leidige problem, d5, 500.0 mg / 1 gramm; wasser, marina, d3, 500.0 mg / 1 gramm - tropfen / spray - d - prunus spinosa, d5, 500.0 mg / 1 gramm; aqua marina, d3, 500.0 mg / 1 gramm - anthroposophisch

캐나다 - 프랑스어 - Health Canada

weleda ag heilmittelbetriebe - prunellier - liquide - 1d - prunellier 1d - homeopathic products

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

weleda ag - prunus leidige problem, d5, 500.0 mg / 1 gramm; wasser, marina, d3, 500.0 mg / 1 gramm - tropfen / spray - d - anthroposophisch